FDA NDC
AKYNZEO
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 69639-101
- Proprietary name
- AKYNZEO
- Nonproprietary name
- Netupitant and Palonosetron
- Labeler
- Helsinn Therapeutics (U.S.), Inc.
- Dosage form
- CAPSULE
- Strength
- 300 mg/1
Run it in Rivvi
Which 2027 plans near you dropped or restricted Netupitant and Palonosetron?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.